Loading clinical trials...
Loading clinical trials...
Comparison of Two Qualia NAD⁺ Formulations on Intracellular NAD⁺ Levels: A Randomized, Double-Blind, Placebo-Controlled Three-Arm Trial
Conditions
Interventions
Qualia NAD⁺ version 1
Qualia NAD⁺ version 2
+1 more
Locations
1
United States
Qualia Life Sciences
Carlsbad, California, United States
Start Date
October 13, 2025
Primary Completion Date
November 30, 2025
Completion Date
December 15, 2025
Last Updated
August 20, 2025
NCT03067181
NCT05732779
NCT06019182
NCT06689085
NCT07348757
NCT07329283
Lead Sponsor
Qualia Life Sciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions